Resmed (RMD) Equity Income (2018 - 2025)
Historic Equity Income for Resmed (RMD) over the last 8 years, with Q4 2025 value amounting to $1.5 million.
- Resmed's Equity Income rose 20528.14% to $1.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$12.9 million, marking a year-over-year decrease of 53298.87%. This contributed to the annual value of -$10.3 million for FY2025, which is 15461.06% down from last year.
- Per Resmed's latest filing, its Equity Income stood at $1.5 million for Q4 2025, which was up 20528.14% from -$6.2 million recorded in Q3 2025.
- In the past 5 years, Resmed's Equity Income registered a high of $24.4 million during Q2 2021, and its lowest value of -$15.5 million during Q2 2024.
- Its 5-year average for Equity Income is $49950.0, with a median of -$2.2 million in 2023.
- In the last 5 years, Resmed's Equity Income surged by 50846.72% in 2021 and then plummeted by 87689.39% in 2024.
- Quarter analysis of 5 years shows Resmed's Equity Income stood at -$4.4 million in 2021, then soared by 290.01% to $8.4 million in 2022, then plummeted by 122.56% to -$1.9 million in 2023, then increased by 23.78% to -$1.4 million in 2024, then surged by 205.28% to $1.5 million in 2025.
- Its Equity Income was $1.5 million in Q4 2025, compared to -$6.2 million in Q3 2025 and -$2.5 million in Q2 2025.